Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward.

Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward.

Bibliographic Details
Main Authors:	Abbas, U, Mellors, J
Format:	Journal article
Language:	English
Published:	2002

Similar Items

Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
by: Bernaschi Massimo, et al.
Published: (2009-10-01)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
by: Dubrocq G, et al.
Published: (2018-06-01)

TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals.
by: Angus, B, et al.
Published: (2008)

Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
by: Evelyn Y. Bonney, et al.
Published: (2021-03-01)

Treatment Interruptions in Chronic HIV Infection.
Published: (2004-12-01)

DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus.
by: Melanie Thompson, et al.
Published: (2016-01-01)

Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals.
by: Katherine E Clarridge, et al.
Published: (2018-01-01)

Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice.
by: John D Ventura, et al.
Published: (2019-12-01)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
by: Gossez, M, et al.
Published: (2018)

Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption
by: You Park, et al.
Published: (2017-11-01)

Pharmacokinetics of rifabutin in Japanese HIV-infected patients with or without antiretroviral therapy.
by: Junko Tanuma, et al.
Published: (2013-01-01)

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial
by: Lewis, J, et al.
Published: (2017)

Is early antiretroviral therapy initiation useful in HIV(+) adults without co-infections?
by: Verónica Chauriye
Published: (2015-12-01)

Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
by: Jana L. Jacobs, et al.
Published: (2019-10-01)

Randomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infection.
by: Cynthia Firnhaber, et al.
Published: (2011-01-01)

Thymic Function as a Predictor of Immune Recovery in Chronically HIV-Infected Patients Initiating Antiretroviral Therapy
by: Rita Rb-Silva, et al.
Published: (2019-02-01)

HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
by: Katleen de Gaetano Donati, et al.
Published: (2010-11-01)

Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption
by: Matthew Pace, et al.
Published: (2022-08-01)

Chronic lung disease in HIV-infected children established on antiretroviral therapy
by: Rylance, J, et al.
Published: (2016)

Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk.
by: Pablo Tebas, et al.
Published: (2008-04-01)

Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response
by: Lorna Leal, et al.
Published: (2020-08-01)

Cortical structural changes related to early antiretroviral therapy (ART) interruption in perinatally HIV-infected children at 5 years of age
by: Emmanuel C. Nwosu, et al.
Published: (2021-06-01)

Antiretroviral therapy of acute HIV-infection
by: A V Kravchenko, et al.
Published: (2004-04-01)

Preventing antiretroviral treatment interruptions among HIV/AIDS patients in Africa.
by: Edward J Mills, et al.
Published: (2013-01-01)

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
by: Samual A. Garner, et al.
Published: (2017-04-01)

HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China
by: Miaomiao Li, et al.
Published: (2021-02-01)

Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV.
by: Alison L Hill, et al.
Published: (2016-04-01)

Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
by: Jillian SY. Lau, et al.
Published: (2021-03-01)

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound
by: P. Zacharopoulou, et al.
Published: (2022-01-01)

Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV
by: A.L. Hill, et al.
Published: (2015-12-01)

31 Systematic review of the current literature on structured treatment interruptions in HIV-infected patients receiving antiretroviral therapy – implications for future HIV cure trials
by: M. Stecher, et al.
Published: (2016-07-01)

Is age and not antiretroviral therapy the strongest risk factor for chronic pain in HIV-infected population?
by: Marcin Kowalski, et al.
Published: (2021-02-01)

Interruption of antiretroviral therapy is associated with increased plasma cystatin C.
by: Mocroft, A, et al.
Published: (2009)

Treatment interruption in chronic HIV-1 infection: does it deliver?
by: Willberg, C, et al.
Published: (2007)

Consequences of HIV/Syphilis Co-Infection on HIV Viral Load and Immune Response to Antiretroviral Therapy
by: Fan L, et al.
Published: (2021-07-01)

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
by: Oxenius, A, et al.
Published: (2002)

Life quality of people infected by hiv with or without antiretroviral treatment
by: N. L. M. Gil
Published: (2009-01-01)

Aortic Stiffness in HIV Infection with and without Antiretroviral Therapy. A Meta-analysis of Observational Studies
by: Giovanni Mulè, et al.
Published: (2020-03-01)

Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era.
by: Alejandro Alvaro-Meca, et al.
Published: (2017-01-01)

IMPROVING ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV INFECTION
by: V. B. Denisenko, et al.
Published: (2018-07-01)